To reconcile our findings of decreased MAL2 protein expression in human HCC, CC and RCC and its anti-oncogenic phenotypes with studies from others where increased MAL2 increased transcript levels were measured in a variety of human carcinoma types, we propose a transcriptional regulatory model for MAL2 transient overexpression. This evidence concerns the gene MAL2 and hepatocellular carcinoma.